Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.06%
#3 CoW Protocol CoW Protocol +41.78%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +26.87%
#6 Codatta Codatta +21.56%
#7 Walrus Walrus +20.27%
#8 Enso Enso +18.27%
#9 The Black Bull The Black Bull +16.62%
#10 Tutorial Tutorial +14.28%
Coin of the day
EXOD EXOD
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Accustem Sciences Inc. Accustem Sciences Inc.

Accustem Sciences Inc.

ACUT
Rang in aandelen #36602
AccuStem Sciences, Inc. operates as a life science firm committed to improving... AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer. Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer. The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers. AccuStem Sciences, Inc. is based in New York, New York.
Aandeelprijs
$0.156
Laatst gesynchroniseerd: 2026-08-13
Marktkapitalisatie
$2.51M
Verandering (1 dag)
2.97%
Verandering (1 jaar)
-91.28%
Land
US
Handel Accustem Sciences Inc. (ACUT)

Categorie

Healthcare
Koersgeschiedenis voor Accustem Sciences Inc. (ACUT)
Hoogste slotkoers: $0.16 op 2026-08-01

Laagste slotkoers: $2.44 op 2022-03-01
Koersgeschiedenis van Accustem Sciences Inc. van 2022 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -4.30%
2025 156.63%
2024 -57.66%
2023 -51.20%
2022 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE